Equities

Blue Jet Healthcare Ltd

BLUEJET:NSI

Blue Jet Healthcare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)515.05
  • Today's Change-1.25 / -0.24%
  • Shares traded54.53k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy1
Outperform1
Hold1
Sell0
Strong Sell0

Share price forecast in INR

The 3 analysts offering 12 month price targets for Blue Jet Healthcare Ltd have a median target of 445.00, with a high estimate of 540.00 and a low estimate of 425.00. The median estimate represents a -13.81% decrease from the last price of 516.30.
High4.6%540.00
Med-13.8%445.00
Low-17.7%425.00

Dividends

In 2024, Blue Jet Healthcare Ltd reported a dividend of 1.00 INR. The 2 analysts covering the company expect dividends of 1.35 INR for the upcoming fiscal year, an increase of 35.00%.
Div growth (TTM)--
More ▼

Earnings history & estimates in INR

On Aug 06, 2024, Blue Jet Healthcare Ltd reported 1st quarter 2025 earnings of 2.18 per share.
Average growth rate-4.80%
Blue Jet Healthcare Ltd reported annual 2024 earnings of 10.00 per share on May 25, 2024.
More ▼

Revenue history & estimates in INR

Blue Jet Healthcare Ltd had 1st quarter 2025 revenues of 1.63bn. This missed the 1.75bn consensus estimate of the 2 analysts following the company. This was 11.44% below the prior year's 1st quarter results.
Average growth rate-11.44%
Blue Jet Healthcare Ltd had revenues for the full year 2024 of 7.12bn. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.